Surgical Innovations Group plc
SUN.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £6,530 | £5,130 | £3,964 | £5,597 |
| - Cash | -£461 | £195 | £232 | £1,212 |
| + Debt | £938 | £1,240 | £911 | £1,662 |
| Enterprise Value | £7,929 | £6,175 | £4,643 | £6,047 |
| Revenue | £6,145 | £5,770 | £6,175 | £6,364 |
| % Growth | 6.5% | -6.6% | -3% | – |
| Gross Profit | £1,921 | £1,402 | £2,034 | £1,445 |
| % Margin | 31.3% | 24.3% | 32.9% | 22.7% |
| EBITDA | £373 | -£1,144 | -£115 | £96 |
| % Margin | 6.1% | -19.8% | -1.9% | 1.5% |
| Net Income | £21 | -£1,456 | -£487 | -£135 |
| % Margin | 0.3% | -25.2% | -7.9% | -2.1% |
| EPS Diluted | 0 | -0.002 | -0.001 | -0 |
| % Growth | 100% | -220% | -400% | – |
| Operating Cash Flow | -£239 | £453 | -£527 | £512 |
| Capital Expenditures | -£25 | -£30 | -£37 | -£383 |
| Free Cash Flow | -£264 | £423 | -£564 | £129 |